Back to search

Sweden· SE-20250908000013

Pylera 140 mg/125 mg/125 mg Kapsel, hård

A medicinal product containing tetracycline hydrochloride + metronidazole + bismuth subcitrate potassium, registered in Sweden by Laboratoires Juvise Pharmaceuticals.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedPylera 140 mg/125 mg/125 mg Kapsel, h…ATC—REGISTER NO.SE-20250908000013PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Tetracycline Hydrochloride + Metronidazole + Bismuth Subcitrate Potassium
Manufacturer
Laboratoires Juvise Pharmaceuticals
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20250908000013

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tetracycline hydrochloride + metronidazole + bismuth subcitrate potassium in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tetracycline hydrochloride + metronidazole + bismuth subcitrate potassium products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Pylera
  • Belgium · Tryplera
  • Bulgaria · Pylera
  • Czechia · Pylera
  • Germany · Pylera
  • Denmark · Pylera
  • Estonia · Pylera
  • Spain · Pylera
  • Finland · Pylera
  • France · Pylera
  • United Kingdom (Northern Ireland) · Pylera
  • Ireland · Pylera
  • Italy · Pylera
  • Lithuania · Pylera
  • Luxembourg · Tryplera
  • Latvia · Pylera
  • Malta · Pylera
  • Norway · Pylera
  • Poland · Pylera
  • Portugal · Pylera
  • Romania · Pylera
  • Slovakia · Pylera

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/90efe378-e646-4dec-bcdd-6711f1873bb7
GET /v1/drugs/90efe378-e646-4dec-bcdd-6711f1873bb7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL"
  ],
  "se_npl_id": "20250908000013",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20250908000013",
  "product_doc_link": "https://docetp.mpa.se/LMF/Pylera%20capsule%2C%20hard%20SmPC_09001bee85121b94.pdf"
}

See everything about tetracycline hydrochloride + metronidazole + bismuth subcitrate potassium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.